Study Looks at Opioid Dispensing Among Youths Undergoing Surgery
By Elana Gotkine HealthDay Reporter
TUESDAY, July 30, 2024 -- Overall, 16.2 percent of opioid-naive youths undergoing a surgical procedure filled an initial opioid prescription one to 14 days before surgery, according to a study published online July 5 in JAMA Network Open.
Tori N. Sutherland, M.D., M.P.H., from the Children's Hospital of Philadelphia, and colleagues characterized changes in preoperative, postoperative, and refill opioid prescriptions up to 180 days after surgery in a retrospective cohort study involving opioid-naive youths aged 11 to 20 years undergoing 22 inpatient and outpatient surgical procedures.
Of the 100,026 opioid-naive youths undergoing a surgical procedure, 46.9 percent filled an initial prescription, 16.2 percent of which were dispensed one to 14 days before surgery. The researchers found that the mean quantity dispensed was 227 morphine milligram equivalents (MME); 13.8 percent of youths filled a second prescription (mean MME, 239) up to 30 days after surgery and 3.0 percent refilled a prescription 91 to 180 days after surgery. Associations with new persistent opioid use were strongest for preoperative prescriptions, increasing age, and procedures not typically associated with severe pain.
"This cohort study identified concerning outcomes, including routine preoperative opioid prescriptions and prolonged refills despite an overall decline in both initial and refill prescriptions," the authors write. "Opioid prescriptions and quantities dispensed were often inconsistent with professional society or guideline recommendations."
One author disclosed ties to Optum HealthCare; a second author disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted July 2024
Read this next
Presurgical Immunotherapy Offers Long-Term Benefit in Melanoma
FRIDAY, July 18, 2025 -- Neoadjuvant systemic treatment (NST) followed by adjuvant treatment with nivolumab and relatlimab offers long-term benefit in adults with stage III/IV...
Velar Adhesion Reduces Cleft Width Prior to Palatoplasty in Cleft Lip
TUESDAY, July 15, 2025 -- For patients with unilateral cleft lip and palate (UCLP), velar adhesion (VA) reduces cleft width prior to palatoplasty and is associated with a lower...
Wearable-Derived Biorhythms Predict Complications After Appendectomy
MONDAY, July 14, 2025 -- Wearable-derived biorhythms can predict postoperative complications in children undergoing appendectomy, according to a study published online July 9 in...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.